Interchangeability of activated clotting time values across different point-of-care systems

American Journal of Cardiology

Volumn 109, Issue 9, 2012, Pages 1379-1382

  Thenappan, Thenappan ^a   Swamy, Rajiv ^a   Shah, Atman ^a   Nathan, Sandeep ^a   Nichols, Jearlyn ^a   Bond, Linda ^a   Jolly, Neeraj ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN;

ACTIVATED CLOTTING TIME; AGED; ANTICOAGULANT THERAPY; ARTICLE; BAND ALTMAN ANALYSIS; BLOOD CLOTTING TEST; COHORT ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; LABORATORY DEVICE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; POINT OF CARE TESTING; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL ANALYSIS;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY DISEASE; FEMALE; HEART CATHETERIZATION; HUMANS; MALE; MONITORING, PHYSIOLOGIC; POINT-OF-CARE SYSTEMS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; WHOLE BLOOD COAGULATION TIME;

EID: 84859805586     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.12.033     Document Type: Article

References (6)

1. Avendaño A, Ferguson JJ. Comparison of Hemochron and HemoTec activated coagulation time target values during percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1994;23:907-910. (Pubitemid 24090876)
2. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310. (Pubitemid 16134762)
3. Ferguson JJ, Dougherty KG, Gaos CM, Bush HS, Marsh KC, Leachman DR. Relation between procedural activated coagulation time and outcome after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1994;23:1061-1065. (Pubitemid 24117135)
4. Narins CR, Hillegass WB Jr, Nelson CL, Tcheng JE, Harrington RA, Phillips HR, Stack RS, Califf RM. Relation between activated clotting time during angioplasty and abrupt closure. Circulation 1996; 93:667-671. (Pubitemid 26052451)
5. Chew DP, Bhatt DL, Lincoff AM, Moliterno DJ, Brener SJ, Wolski KE, Topol EJ. Defining the optimal activated clotting time during percutaneous coronary intervention: aggregate results from 6 randomized, controlled trials. Circulation 2001;103:961-966. (Pubitemid 32183801)
6. King SB III, Smith SC Jr, Hirshfeld JW Jr, Jacobs AK, Morrison DA, Williams DO, Feldman TE, Kern MJ, O'Neill WW, Schaff HV, Whitlow PL, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Page RL, Riegel B, Tarkington LG, Yancy CW. 2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2008;51:172-209.